Literature DB >> 21476195

Expression of GFP can influence aging and climbing ability in Drosophila.

R M S Mawhinney1, B E Staveley.   

Abstract

Green fluorescent protein (GFP) is widely used as a reporter transgene in a variety of organisms. Some of the advantages of using GFP include non-invasive visualization of biological events and/or tissues in live specimens and its benign nature. When GFP is expressed throughout the organism, in neurons and eyes, lifespan and climbing ability of flies are significantly decreased compared to similar crosses with a lacZ reporter. Also, GFP expression can have subtle effects on eye morphology, with neural and ubiquitous expression. Since GAL4/UAS expression of GFP can influence aging and climbing ability in the Drosophila system of directed gene expression, we found that the latter of these advantages, namely its harmless, non-toxic nature, can be conditional, depending upon the mode of expression and the biological endpoint. We suggest that caution should be used when using GFP to visualize cellular events, especially in long-term assays.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21476195     DOI: 10.4238/vol10-1gmr1023

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Vitellogenin family gene expression does not increase Drosophila lifespan or fecundity.

Authors:  Yingxue Ren; Kimberly A Hughes
Journal:  F1000Res       Date:  2014-06-10

2.  Handheld confocal laser endomicroscopic imaging utilizing tumor-specific fluorescent labeling to identify experimental glioma cells in vivo.

Authors:  Nikolay L Martirosyan; Joseph Georges; M Yashar S Kalani; Peter Nakaji; Robert F Spetzler; Burt G Feuerstein; Mark C Preul
Journal:  Surg Neurol Int       Date:  2016-12-12

3.  The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity.

Authors:  Marie A Brunet; Jean-Francois Jacques; Sonya Nassari; Giulia E Tyzack; Philip McGoldrick; Lorne Zinman; Steve Jean; Janice Robertson; Rickie Patani; Xavier Roucou
Journal:  EMBO Rep       Date:  2020-11-23       Impact factor: 9.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.